171 related articles for article (PubMed ID: 38789185)
1. Innovative target mining stratagems to navigate drug repurposing endeavours.
Saravanan KS; Satish KS; Saraswathy GR; Kuri U; Vastrad SJ; Giri R; Dsouza PL; Kumar AP; Nair G
Prog Mol Biol Transl Sci; 2024; 205():303-355. PubMed ID: 38789185
[TBL] [Abstract][Full Text] [Related]
2. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing.
G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP
Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476
[TBL] [Abstract][Full Text] [Related]
3. Computational Drug Repurposing: Current Trends.
Karaman B; Sippl W
Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
[TBL] [Abstract][Full Text] [Related]
4. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
5. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
[TBL] [Abstract][Full Text] [Related]
6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
7. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
[TBL] [Abstract][Full Text] [Related]
9. Current approaches in identification of a novel drug targets for drug repurposing.
Khambhati K; Singh V
Prog Mol Biol Transl Sci; 2024; 205():213-220. PubMed ID: 38789179
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
Mottini C; Napolitano F; Li Z; Gao X; Cardone L
Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
[TBL] [Abstract][Full Text] [Related]
11. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of biologics and biopharmaceuticals.
Israr J; Alam S; Singh V; Kumar A
Prog Mol Biol Transl Sci; 2024; 205():277-302. PubMed ID: 38789184
[TBL] [Abstract][Full Text] [Related]
13. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
14. Synergizing drug repurposing and target identification for neurodegenerative diseases.
Sahu M; Vashishth S; Kukreti N; Gulia A; Russell A; Ambasta RK; Kumar P
Prog Mol Biol Transl Sci; 2024; 205():111-169. PubMed ID: 38789177
[TBL] [Abstract][Full Text] [Related]
15. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
Padhy BM; Gupta YK
J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
[TBL] [Abstract][Full Text] [Related]
16. Considerations and challenges for sex-aware drug repurposing.
Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
[TBL] [Abstract][Full Text] [Related]
17. Signature-based approaches for informed drug repurposing: targeting CNS disorders.
Shukla R; Henkel ND; Alganem K; Hamoud AR; Reigle J; Alnafisah RS; Eby HM; Imami AS; Creeden JF; Miruzzi SA; Meller J; Mccullumsmith RE
Neuropsychopharmacology; 2021 Jan; 46(1):116-130. PubMed ID: 32604402
[TBL] [Abstract][Full Text] [Related]
18. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
Jain P; Jain SK; Jain M
Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
[TBL] [Abstract][Full Text] [Related]
20. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
